Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei: Imaging Features and Current Therapies
- 1 June 2025
- journal article
- review article
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (6) , e240131
Abstract
Radiologists are integral members of the interdisciplinary team for patients with mucinous appendiceal neoplasms and can directly affect care by suggesting the diagnosis of pseudomyxoma peritonei, optimizing imaging protocols for evaluating peritoneal implants, and reporting the primary tumor and spilled tumor cells thoroughly.Keywords
This publication has 52 references indexed in Scilit:
- Efficacy of Systemic Chemotherapy in Patients With Low-grade Mucinous Appendiceal AdenocarcinomaJAMA Network Open, 2023
- The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive SurgeryJAMA Surgery, 2021
- The Chicago Consensus on peritoneal surface malignancies: Management of appendiceal neoplasmsCancer, 2020
- Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritoneiEuropean Radiology, 2019
- FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritoneiEuropean Journal of Nuclear Medicine and Molecular Imaging, 2016
- The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data BaseCancer, 2015
- Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosisBritish Journal of Surgery, 2013
- AJCC Cancer Staging ManualJAMA, 2010
- Dynamic Radiology of the Abdomen1982
- Ultrasound findings in a patient with pseudomyxoma peritoneiJournal of Clinical Ultrasound, 1978